These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 32880034)

  • 1. ASO Author Reflections: Validated Prediction Model of Early Recurrence after Resection for Gallbladder Cancer: Identifying a Subset of Patients Who May be Better Served with Neoadjuvant Therapy.
    Sahara K; Tsilimigras DI; Pawlik TM
    Ann Surg Oncol; 2021 Jan; 28(1):428-429. PubMed ID: 32880034
    [No Abstract]   [Full Text] [Related]  

  • 2. ASO Author Reflections: Contemporary Analysis of Impact of Lymphadenectomy on Survival in Nonmetastatic Gallbladder Cancer.
    Kemp Bohan PM; Nelson DW; Vreeland TJ
    Ann Surg Oncol; 2021 Jun; 28(6):2973-2974. PubMed ID: 33560490
    [No Abstract]   [Full Text] [Related]  

  • 3. ASO Author Reflections: Preoperative Prediction Score for Early Recurrence of Resected Gallbladder Carcinoma and Consideration of Optimal Treatment Strategies.
    Shimizu Y; Ashida R; Sugiura T; Okamura Y; Ohgi K; Yamada M; Otsuka S; Aramaki T; Notsu A; Uesaka K
    Ann Surg Oncol; 2022 Sep; 29(9):5458-5459. PubMed ID: 35650368
    [No Abstract]   [Full Text] [Related]  

  • 4. ASO Author Reflections: Failing to Adhere to Treatment Guidelines in Gallbladder Cancer.
    Papageorge MV; Sachs TE
    Ann Surg Oncol; 2021 Jun; 28(6):2958-2959. PubMed ID: 33555452
    [No Abstract]   [Full Text] [Related]  

  • 5. ASO Author Reflections: Gallbladder Cancer Research, "One for All and All for One" Strategy to Improve Research.
    Vega EA; Newhook TE; Vauthey JN
    Ann Surg Oncol; 2021 May; 28(5):2683-2684. PubMed ID: 33718976
    [No Abstract]   [Full Text] [Related]  

  • 6. ASO Author Reflections: Precision in Gallbladder Cancer Care: Present Challenges and Future Directions.
    Mellado S; Chirban AM; Rivera B; Panettieri E; Vega EA
    Ann Surg Oncol; 2023 Oct; 30(11):6601-6602. PubMed ID: 37548834
    [No Abstract]   [Full Text] [Related]  

  • 7. ASO Author Reflections: Tumor Necrosis-A Poor Prognostic Factor of Gallbladder Carcinoma.
    Zou RQ; Yang SQ; Dai YS; Hu HJ; Li FY
    Ann Surg Oncol; 2024 Jan; 31(1):152-153. PubMed ID: 37930499
    [No Abstract]   [Full Text] [Related]  

  • 8. ASO Author Reflections: Robotic Radical Surgery for Incidental Gallbladder Cancer is on the Rise.
    Machado MAC; Lobo Filho M; Makdissi F
    Ann Surg Oncol; 2023 Jun; 30(6):3398-3399. PubMed ID: 36967452
    [No Abstract]   [Full Text] [Related]  

  • 9. Selecting treatment sequence for patients with incidental gallbladder cancer: a neoadjuvant approach versus upfront surgery.
    Cherkassky L; Jarnagin W
    Updates Surg; 2019 Jun; 71(2):217-225. PubMed ID: 31254234
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ASO Author Reflections: Comprehensive Clinical Analysis of Gallbladder Neuroendocrine Neoplasms.
    Zhang Q; Wang Y; Liang T
    Ann Surg Oncol; 2022 Nov; 29(12):7631. PubMed ID: 35794367
    [No Abstract]   [Full Text] [Related]  

  • 11. Rates and patterns of recurrence after curative intent resection for gallbladder cancer: a multi-institution analysis from the US Extra-hepatic Biliary Malignancy Consortium.
    Margonis GA; Gani F; Buettner S; Amini N; Sasaki K; Andreatos N; Ethun CG; Poultsides G; Tran T; Idrees K; Isom CA; Fields RC; Krasnick B; Weber SM; Salem A; Martin RC; Scoggins C; Shen P; Mogal HD; Schmidt C; Beal E; Hatzaras I; Shenoy R; Maithel SK; Pawlik TM
    HPB (Oxford); 2016 Nov; 18(11):872-878. PubMed ID: 27527802
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ASO Author Reflections: Impact of Neoadjuvant Therapy on Survival After Margin-Positive Resection for Pancreatic Cancer.
    Chopra A; Beane JD
    Ann Surg Oncol; 2021 Nov; 28(12):7770-7771. PubMed ID: 34028634
    [No Abstract]   [Full Text] [Related]  

  • 13. [Primary carcinoma of the gallbladder: report of 41 cases (author's transl)].
    Salcuni P; Zola C; Foggi E; Manfredi A
    Ateneo Parmense Acta Biomed; 1980; 51(2):87-92. PubMed ID: 6163438
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ASO Author Reflections: Prediction of the Therapeutic Efficacy in Patients with Neoadjuvant Chemotherapy for Esophageal Squamous Cell Carcinoma.
    Okamura A; Matsuda S; Kawakubo H; Mine S; Takeuchi H; Kitagawa Y; Watanabe M
    Ann Surg Oncol; 2020 Dec; 27(Suppl 3):795-796. PubMed ID: 32591950
    [No Abstract]   [Full Text] [Related]  

  • 15. The role of neoadjuvant chemotherapy or chemoradiotherapy for advanced gallbladder cancer - A systematic review.
    Hakeem AR; Papoulas M; Menon KV
    Eur J Surg Oncol; 2019 Feb; 45(2):83-91. PubMed ID: 30287098
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ASO Author Reflections: Neoadjuvant Therapy Versus Upfront Resection for Pancreatic Cancer.
    Andrianello S; Marchegiani G; Salvia R
    Ann Surg Oncol; 2018 Dec; 25(Suppl 3):810-811. PubMed ID: 30374921
    [No Abstract]   [Full Text] [Related]  

  • 17. ASO Author Reflections: ypTNM Stage Grouping in the 8th Edition of the AJCC Cancer Staging Manual Refines the Prognostic Prediction for Patients with Esophageal Squamous Cell Carcinoma Undergoing Neoadjuvant Chemotherapy.
    Sudo N; Ichikawa H; Muneoka Y; Hanyu T; Kano Y; Ishikawa T; Hirose Y; Miura K; Shimada Y; Nagahashi M; Sakata J; Kobayashi T; Bamba T; Nakagawa S; Kosugi SI; Wakai T
    Ann Surg Oncol; 2021 Feb; 28(2):661-662. PubMed ID: 33001302
    [No Abstract]   [Full Text] [Related]  

  • 18. ASO Author Reflections: Recurrence Following Post-neoadjuvant Pancreatectomy: How Can We Do Better?
    Maggino L; Malleo G; Crippa S; Falconi M; Salvia R
    Ann Surg Oncol; 2023 Jan; 30(1):220-221. PubMed ID: 36227393
    [No Abstract]   [Full Text] [Related]  

  • 19. Laparoscopic cholecystectomy can disseminate in situ carcinoma of the gallbladder.
    Wibbenmeyer LA; Wade TP; Chen RC; Meyer RC; Turgeon RP; Andrus CH
    J Am Coll Surg; 1995 Dec; 181(6):504-10. PubMed ID: 7582223
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ASO Author Reflections: Survival Benefit of Adjuvant Chemoradiotherapy for Gallbladder Cancer: The Role of Radiation Therapy Revisited.
    Kim BH; Chie EK; Kim K
    Ann Surg Oncol; 2018 Dec; 25(Suppl 3):788-789. PubMed ID: 30324480
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.